ArticleScientific reports2026
Val109 and Ile170 contribute to channel function in Guillardia theta-derived anion channelrhodopsins.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Anion channelrhodopsins (ACRs) are widely used for optical silencing of neurons. Photocurrents and kinetics are crucial for the precise control of cell hyperpolarization. In this study, we investigated the roles of amino acid residues in each transmembrane domain of the Guillardia theta-derived anion channelrhodopsins, GtACR1 and GtACR2, to develop high-performance ACRs. Several chimaera ACRs were generated by replacing the transmembrane (TM) domains of GtACR1 with homologous counterparts of GtACR2, and photocurrents in HEK cells transduced with each variant were recorded by patch-clamp. The relationship between photocurrent and protein localisation was determined. Chimaeras of TM4, TM5, and TM6 in GtACR1 replaced with the homologous counterparts of GtACR2 showed wavelength changes and fast kinetics(τ
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.